Refractory Primary Mediastinal Large B-Cell Lymphoma

specific

A primary mediastinal large B-cell lymphoma that is resistant to treatment.

19

Centers

17

Active Trials

—

Cancer Funding

Top Centers for Refractory Primary Mediastinal Large B-Cell Lymphoma(19)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
High-Volume Research Center
73.9
2
Siteman Cancer CenterSt. Louis, MO
NCI Comprehensive
Active Research Program
55.0
3
Mayo Clinic Comprehensive Cancer CenterRochester, MN
NCI Comprehensive
Active Research Program
55.0
4
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
Active Research Program
55.0
5
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
Active Research Program
55.0
6
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY
NCI Comprehensive
Active Research Program
55.0
7
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
Active Research Program
55.0
8
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
55.0
9
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
Active Research Program
55.0
10
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
Active Research Program
55.0
11
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
Active Research Program
55.0
12
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
Active Research Program
55.0
13
Dartmouth Cancer CenterLebanon, NH
NCI Comprehensive
Active Research Program
55.0
14
University of Illinois Cancer CenterChicago, IL
Active Research Program
55.0
15
Cancer Center at IllinoisUrbana, IL
Active Research Program
55.0
16
Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ
Active Research Program
55.0
17
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
33.7
18
Huntsman Cancer Institute at the University of UtahSalt Lake City, UT
NCI Comprehensive
33.7
19
Holden Comprehensive Cancer CenterIowa City, IA
NCI Comprehensive
33.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →